Skip to main content
. 2011 Jun;85(12):5880–5888. doi: 10.1128/JVI.02643-10

Fig. 3.

Fig. 3.

The proportion of CD4+ (A, C, and D) or CD8+ (B, E, and F) T cells with activated (HLA-DR+ CD38+) (A and B) or cycling (Ki67+) (C to F) phenotype was quantified by flow cytometry. Activation phenotype was determined only for PBMC. Mann-Whitney tests were used for between-group comparisons.